Stoke Therapeutics Inc (STOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.60 +0.49 (+6.04%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.60 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,442 | 113,556 | 144,895 | 287,308 | 222,471 |
| Marketable Securities | 9,952 | 116,039 | 74,915 | N/A | N/A |
| Receivables | 64 | 588 | 132 | 6 | 281 |
| Other current assets | 2,561 | 2,955 | 2,333 | 181 | 0 |
| TOTAL | $215,339 | $244,070 | $229,218 | $293,930 | $226,033 |
| Non-Current Assets | |||||
| PPE Net | 5,823 | 6,675 | 4,139 | 2,675 | 2,512 |
| Other Non-Current Assets | 7,180 | 5,322 | 5,508 | 1,320 | 205 |
| TOTAL | $13,003 | $11,997 | $9,647 | $3,995 | $2,717 |
| Total Assets | $228,342 | $256,067 | $238,865 | $297,925 | $228,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,695 | 766 | 2,385 | 1,495 | 751 |
| Accrued Expenses | 13,815 | 15,748 | 14,754 | 9,930 | 3,350 |
| TOTAL | $30,819 | $31,394 | $17,139 | $11,425 | $4,101 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,309 | 14,880 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 4,884 | 2,968 | 3,949 | 422 | 221 |
| TOTAL | $37,958 | $39,824 | $3,949 | $422 | $221 |
| Total Liabilities | $68,777 | $71,218 | $21,088 | $11,847 | $4,322 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,304 | 44,148 | 37,359 | 36,664 | 32,944 |
| Common Shares | 5 | 4 | 4 | 4 | 3 |
| Retained earnings | -401,849 | -297,150 | -196,083 | -110,278 | -58,035 |
| Other shareholders' equity | -24 | -1,175 | -168 | 0 | 0 |
| TOTAL | $159,565 | $184,849 | $217,777 | $286,078 | $224,428 |
| Total Liabilities And Equity | $228,342 | $256,067 | $238,865 | $297,925 | $228,750 |